INS and Alzheimer disease: Indeed, in agreement with our “Neuroenergetic hypothesis”, aberrant insulin signaling, and energy deficit may well be predisposing metabolic conditions for both the main pathological changes in AD, the Aβ deposition and tau hyperphosphorylation [18, 44, 45, 205] (Figure 2).